Page last updated: 2024-12-07
3,4-dimethoxybenzylamine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
3,4-dimethoxybenzylamine: RN given for parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 79832 |
| SCHEMBL ID | 44393 |
| MeSH ID | M0190825 |
Synonyms (54)
| Synonym |
|---|
| HMS1749O10 |
| 4-13-00-02582 (beilstein handbook reference) |
| 3,4-dimethoxybenzylamine |
| benzenemethanamine,4-(dimethoxy)- |
| veratrylamine |
| nsc271740 |
| benzenemethanamine,4-dimethoxy- |
| 5763-61-1 |
| benzylamine,4-(dimethoxy)- |
| nsc-271740 |
| wln: z1r co1 do1 |
| 3,4-(dimethoxy)benzylamine |
| inchi=1/c9h13no2/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5h,6,10h2,1-2h |
| 3,4-dimethoxybenzylamine, 97% |
| benzylamine, 3,4-dimethoxy- |
| nsc 271740 |
| benzenemethanamine, 3,4-dimethoxy- |
| einecs 227-287-7 |
| brn 0511575 |
| STK397311 |
| 1-(3,4-dimethoxyphenyl)methanamine |
| (3,4-dimethoxyphenyl)methanamine |
| AKOS000120468 |
| D4024 |
| FT-0635841 |
| BBL027681 |
| SCHEMBL44393 |
| veratrylamin |
| 3,4-dimethoxyphenylmethyl amine |
| 3,4-dimethoxy -benzylamine |
| 3,4-dimethoxybenzenemethanamine |
| 3,4-dimethoxy benzyl amine |
| 1-(3,4-dimethoxyphenyl)methaneamine |
| 1-(aminomethyl)-3,4-dimethoxybenzene |
| 3,4-dimethoxybenzyl-amine |
| 3,4-dimethoxy-benzylamine |
| 3,4-dimethoxybenzyl amine |
| 3,4-dimethoxy benzylamine |
| 3,4-di-methoxybenzylamine |
| benzylamine, 3,4-(dimethoxy)- |
| (3,4-dimethoxyphenyl)methanamine # |
| W-105453 |
| TS-01461 |
| F0001-1502 |
| DTXSID50206292 |
| mfcd00008116 |
| (3,4-dimethoxybenzyl)amine |
| BCP18641 |
| KQA442BL6W |
| [(3,4-dimethoxyphenyl)methyl]amine |
| EN300-17919 |
| JHD , |
| CK2400 |
| CS-W017837 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 22.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.06) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||